AJMC ®: How would you characterize the state of precision medicine in oncology and its rapid evolution in recent years? Paulson: The era of HER2 mutations and hormone receptor status in breast cancer ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
Throughout the workshop, participants returned to Hayes’ proposal that the LDT pathway be eliminated and all genomic diagnostic tests be reviewed and approved by FDA. Several participants pointed to ...
ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to ...
In screening for prostate cancer, the risk of overdiagnosis can be halved, a University of Gothenburg study shows. With the diagnostic pathway that has now been tried out, considerably fewer harmless ...
Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer-reviewed Journal of Clinical Psychiatry (JCP), a widely read ...
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that researchers from ...
Many FDA-regulated companies are exploring ways to support diagnostic testing, especially when early diagnosis can impact treatment options. However, funding diagnostic testing tied to a company’s own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results